Actively Recruiting
Detection and Prevention of Cancer-Related Cardiovascular Toxicity Registry
Led by University of Bologna · Updated on 2025-06-19
10000
Participants Needed
5
Research Sites
87 weeks
Total Duration
On this page
Sponsors
U
University of Bologna
Lead Sponsor
A
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study is being done in order to assess the cardiovascular events known as cardiovascular toxicity of chemotherapy agents and radiotherapy protocols in cancer subjects to identify risk prediction, prevention and treatment of cancer therapy-related cardiovascular toxicity and cancer therapy-related cardiac dysfunction
CONDITIONS
Official Title
Detection and Prevention of Cancer-Related Cardiovascular Toxicity Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years old or older
- Capable of giving informed consent
- Diagnosis of cancer scheduled for treatment according to treating physician's discretion
- Life expectancy >1 year
- Newly diagnosed breast cancer undergoing treatment with anthracyclines analogues with or without radiotherapy, with or without trastuzumab, or other anticancer drugs (for prospective HFA-ICOS risk score validation)
You will not qualify if you...
- Age <18 years old
- Not able to give informed consent
- Life expectancy <1 year
- Advanced-stage cancer not eligible for treatment (subjects with an indication of palliative care) according to treating physician's
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
University of Bologna
Bologna, Italy
Not Yet Recruiting
2
Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone"
Palermo, Italy
Not Yet Recruiting
3
Ss. Cyril and Methodius University in Skopje, University Clinic
Skopje, North Macedonia
Actively Recruiting
4
University of Belgrade, Clinical Center of Serbia
Belgrade, Serbia
Actively Recruiting
5
University of Belgrade, Clinical Hospital Center Bezanijska kosa
Belgrade, Serbia
Actively Recruiting
Research Team
E
Edina Cenko
CONTACT
M
Maria Bergami
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here